Treatment outcomes of bedaquiline-resistant tuberculosis: a retrospective and matched cohort study
Authors:
Open Access
- 18 June 2025
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 25 (10) , 1149-1158
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Wellcome Trust (214321/Z/18/Z, 203135/Z/16/Z)
- National Research Foundation (64787)
- Hjärt-Lungfonden (20240774, 20220859)
- Bill & Melinda Gates Foundation
- National Institutes of Health National Institute of Allergy and Infectious Diseases (U01AI170426)
- South African Medical Research Council (MRC-RFA-SHIP 02\u20132018)
- National Institute for Health and Care Research (CL-2023-16-002)
- Swedish Society of Medicine (SLS-985976)
- Department of Science and Technology, Republic of South Africa
- National Institutes of Health
This publication has 22 references indexed in Scilit:
- Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational studyThe Lancet Infectious Diseases, 2023
- Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort studyThe Lancet Microbe, 2023
- Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort studyThe Lancet Infectious Diseases, 2022
- Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal studyThe Lancet Infectious Diseases, 2022
- Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysisThe Lancet Microbe, 2020
- Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysisThe Lancet, 2018
- Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort studyThe Lancet Respiratory Medicine, 2018
- Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort studyThe Lancet, 2014
- Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projectsTuberculosis, 2012
- Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007JAMA, 2008